OrbiMed Capital GP VII LLC
Insider CIK 1760648 · SRRA Director, 10% owner · THOR 10% owner · QTTB Director, 10% owner · KROS Director · IMRA Director, 10% owner · THRX Director, 10% owner · MBX Director, 10% owner · PASG 10% owner · ARQT Director, 10% owner · KNTE Director, 10% owner · GLTO Director, 10% owner · ADRX Director, 10% owner · FUSN Director · RPTX Director · JANX Director · TERN Director, 10% owner · NONE Director · THRD Director, 10% owner · ETRA Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 588,235 | $17.00 | $10.00M | 588,235 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 61,516 | $17.00 | $1.05M | 9,292,025 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 10,690,530 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 12,691,492 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 13,461,093 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 9,230,509 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 8,974,061 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 8,460,994 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 7,127,019 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 300,249 | $17.00 | $5.10M | 14,325,529 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 14,025,280 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 588,235 | $17.00 | $10.00M | 588,235 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 61,516 | $17.00 | $1.05M | 9,292,025 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 256,448 | — | — | 9,230,509 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 513,067 | — | — | 8,974,061 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 1,333,975 | — | — | 8,460,994 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 7,127,019 | — | — | 7,127,019 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 300,249 | $17.00 | $5.10M | 14,325,529 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 564,187 | — | — | 14,025,280 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 769,601 | — | — | 13,461,093 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 2,000,962 | — | — | 12,691,492 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 10,690,530 | — | — | 10,690,530 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 333,333 | $15.00 | $5.00M | 5,126,891 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 3,090,244 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 1,000,000 | $15.00 | $15.00M | 1,758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 4,793,558 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 2,002,310 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 1,000,000 | $15.00 | $15.00M | 1,758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 758,279 | — | — | 758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 333,333 | $15.00 | $5.00M | 5,126,891 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,703,314 | — | — | 4,793,558 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,087,934 | — | — | 3,090,244 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 2,002,310 | — | — | 2,002,310 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 1,477 | $45.00 | $66.5K | 219,405 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 787,024 | $45.38 | $35.72M | 6,601,878 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 46,776 | $45.00 | $2.10M | 6,555,102 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 24,846 | $45.38 | $1.13M | 220,882 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-15 | 2026-06-17 | 272,322 | $45.02 | $12.26M | 7,388,902 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-15 | 2026-06-17 | 9,086 | $45.02 | $409.1K | 245,728 | SEC↗ |
| QTTB Q32 Bio Inc. | P Buy | 2026-05-28 | 2026-06-01 | 1,250,000 | $8.00 | $10.00M | 3,502,987 | SEC↗ |
| QTTB Q32 Bio Inc. | P Buy | 2026-05-28 | 2026-06-01 | 625,000 | $8.00 | $5.00M | 625,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | D To issuer | 2025-11-21 | 2025-12-18 | 74,465 | $17.75 | $1.32M | 45,057 | SEC↗ |
| KROS Keros Therapeutics, Inc. | D To issuer | 2025-11-21 | 2025-12-18 | 140,057 | $17.75 | $2.49M | 759,155 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-06-26 | 2025-06-26 | 213,257 | $0.33 | $70.4K | 6,066,343 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-06-25 | 2025-06-26 | 138,800 | $0.33 | $45.8K | 6,279,600 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-06-24 | 2025-06-26 | 231,600 | $0.35 | $81.1K | 6,418,400 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-04-24 | 2025-04-24 | 68,195 | $0.32 | $21.8K | 6,650,000 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-04-23 | 2025-04-24 | 89,328 | $0.34 | $30.4K | 6,718,195 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-04-22 | 2025-04-24 | 78,049 | $0.34 | $26.5K | 6,807,523 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-04-17 | 2025-04-17 | 77,090 | $0.33 | $25.4K | 6,885,572 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-04-16 | 2025-04-17 | 61,638 | $0.33 | $20.3K | 6,962,662 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-04-15 | 2025-04-17 | 10,326 | $0.38 | $3.9K | 7,024,300 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-18 | 2025-02-19 | 49,070 | $10.84 | $531.9K | 3,255,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-18 | 2025-02-19 | 94,100 | $10.84 | $1.02M | 747,887 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-14 | 2025-02-19 | 29,540 | $9.85 | $291.0K | 3,205,930 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-14 | 2025-02-19 | 17,962 | $9.90 | $177.8K | 3,176,390 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-01-14 | 2025-01-14 | 79,024 | $0.60 | $47.4K | 7,034,626 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-01-13 | 2025-01-14 | 17,986 | $0.64 | $11.5K | 7,113,650 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-01-10 | 2025-01-14 | 126,209 | $0.66 | $83.3K | 7,131,636 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-01-08 | 2025-01-08 | 75,007 | $0.68 | $51.0K | 7,257,845 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-01-07 | 2025-01-08 | 52,536 | $0.71 | $37.3K | 7,332,852 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2025-01-06 | 2025-01-08 | 19,481 | $0.77 | $15.0K | 7,385,388 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2024-12-20 | 2024-12-26 | 230,321 | $0.60 | $138.2K | 7,404,869 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2024-12-11 | 2024-12-11 | 80 | $0.80 | $64 | 7,635,190 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2024-12-10 | 2024-12-11 | 8,015 | $0.80 | $6.4K | 7,635,270 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2024-12-09 | 2024-12-11 | 54,181 | $0.84 | $45.5K | 7,643,285 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2024-12-06 | 2024-12-06 | 20,903 | $0.82 | $17.1K | 7,697,466 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2024-12-04 | 2024-12-06 | 76,200 | $0.79 | $60.2K | 7,718,369 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 215,146 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 389,078 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 230,753 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 74,613 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 323,916 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 215,146 | $3.20 | $688.5K | 539,062 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 230,753 | $3.60 | $830.7K | 1,158,893 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 74,613 | $3.60 | $268.6K | 1,233,506 | SEC↗ |
| NONE Lomond Therapeutics Holdin | A Award | 2024-11-01 | 2024-11-05 | 808,894 | $4.00 | $3.24M | 2,042,400 | SEC↗ |
| NONE Lomond Therapeutics Holdin | A Award | 2024-11-01 | 2024-11-05 | 479,736 | $4.00 | $1.92M | 2,522,136 | SEC↗ |
| NONE Lomond Therapeutics Holdin | A Award | 2024-11-01 | 2024-11-05 | 155,120 | $4.00 | $620.5K | 2,677,256 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 389,078 | $3.60 | $1.40M | 928,140 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 323,916 | $3.20 | $1.04M | 323,916 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2024-09-19 | 2024-09-23 | 39,300 | $0.71 | $27.9K | 7,794,569 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2024-09-18 | 2024-09-18 | 25,631 | $0.73 | $18.7K | 7,833,869 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2024-09-17 | 2024-09-18 | 111,400 | $0.73 | $81.3K | 7,859,500 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 4,854,368 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 19,587,284 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,372,634 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 250,000 | $16.00 | $4.00M | 653,787 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 403,787 | — | $0 | 403,787 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,158,428 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 2,658,428 | — | $0 | 2,658,428 | SEC↗ |
| PASG Passage BIO, Inc. | S Sale | 2024-09-16 | 2024-09-18 | 63,100 | $0.74 | $46.7K | 7,970,900 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 220,600 | $44.01 | $9.71M | 899,212 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 29,400 | $44.01 | $1.29M | 119,522 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-16 | 2024-07-17 | 556 | $10.00 | $5.6K | 1,967,924 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-16 | 2024-07-17 | 4,009 | $10.00 | $40.1K | 4,839,412 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-16 | 2024-07-17 | 623 | $10.00 | $6.2K | 755,635 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-15 | 2024-07-17 | 39,433 | $10.00 | $394.3K | 4,843,421 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-15 | 2024-07-17 | 5,401 | $10.00 | $54.0K | 1,968,480 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-15 | 2024-07-17 | 6,142 | $10.00 | $61.4K | 756,258 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-16 | 2024-05-20 | 1,000,000 | $22.14 | $22.14M | 7,663,349 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-16 | 2024-05-20 | 33,300 | $22.14 | $737.3K | 254,814 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 84,599 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 450,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,338 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,339 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 4,738,453 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | U Tender | 2024-02-14 | 2024-02-14 | 17,063,000 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | U Tender | 2024-02-14 | 2024-02-14 | 650,600 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-08-15 | 2023-08-17 | 248,819 | $0.75 | $186.6K | 631,048 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-08-15 | 2023-08-17 | 38,327 | $0.75 | $28.7K | 97,204 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-08-15 | 2023-08-17 | 535,534 | $0.75 | $401.7K | 1,510,375 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-31 | 2023-08-02 | 153,078 | $3.00 | $459.2K | 2,105,909 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-31 | 2023-08-02 | 29,700 | $3.00 | $89.1K | 879,867 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-31 | 2023-08-02 | 26,622 | $3.00 | $79.9K | 135,531 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-25 | 2023-07-27 | 4,700 | $2.92 | $13.7K | 909,567 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-25 | 2023-07-27 | 7,800 | $2.92 | $22.8K | 162,153 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-25 | 2023-07-27 | 26,700 | $2.92 | $78.0K | 2,258,987 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2023-07-17 | 2023-07-19 | 151,450 | $3.05 | $461.9K | 650,600 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2023-07-17 | 2023-07-19 | 328,482 | $3.05 | $1.00M | 17,063,000 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-13 | 2023-07-17 | 52,800 | $2.40 | $126.7K | 914,267 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-13 | 2023-07-17 | 132,100 | $2.40 | $317.0K | 2,285,687 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-13 | 2023-07-17 | 9,800 | $2.40 | $23.5K | 169,953 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2023-06-28 | 2023-06-29 | 575,195 | $0.84 | $483.2K | 8,034,000 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 617,382 | $0.84 | $518.6K | 7,458,805 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-05-17 | 2023-05-19 | 2,125 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-05-17 | 2023-05-19 | 2,125 | $4.28 | $9.1K | 8,663,349 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,512 | $2.82 | $1.38M | 1,368,339 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,511 | $2.82 | $1.38M | 1,368,338 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 312,991 | $2.75 | $860.7K | 4,738,453 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 220,610 | $2.67 | $589.0K | 4,425,462 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,544 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 467,068 | $2.62 | $1.22M | 4,204,852 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,545 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 228,754 | $2.55 | $583.3K | 3,737,784 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,997 | $2.55 | $155.5K | 610,997 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,998 | $2.55 | $155.5K | 610,998 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-17 | 2023-04-17 | 660 | $1.97 | $1.3K | 179,753 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-17 | 2023-04-17 | 8,878 | $1.97 | $17.5K | 2,417,787 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-17 | 2023-04-17 | 3,551 | $1.97 | $7.0K | 967,067 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-14 | 2023-04-17 | 28,110 | $1.86 | $52.3K | 2,426,665 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-14 | 2023-04-17 | 11,245 | $1.86 | $20.9K | 970,618 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-14 | 2023-04-17 | 2,091 | $1.86 | $3.9K | 180,413 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-13 | 2023-04-17 | 703 | $1.82 | $1.3K | 182,504 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-13 | 2023-04-17 | 3,784 | $1.82 | $6.9K | 981,863 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-13 | 2023-04-17 | 9,459 | $1.82 | $17.2K | 2,454,775 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-12 | 2023-04-12 | 641 | $1.81 | $1.2K | 985,647 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-12 | 2023-04-12 | 119 | $1.81 | $215 | 183,207 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-12 | 2023-04-12 | 1,603 | $1.81 | $2.9K | 2,464,234 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-11 | 2023-04-12 | 3,784 | $1.82 | $6.9K | 986,288 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-11 | 2023-04-12 | 703 | $1.82 | $1.3K | 183,326 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-11 | 2023-04-12 | 9,459 | $1.82 | $17.2K | 2,465,837 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 34,745 | $1.79 | $62.2K | 2,500,582 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 13,899 | $1.79 | $24.9K | 1,000,187 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 2,584 | $1.79 | $4.6K | 185,910 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-06 | 2023-04-07 | 487 | $2.00 | $974 | 186,613 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-06 | 2023-04-07 | 2,620 | $2.00 | $5.2K | 1,003,971 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-06 | 2023-04-07 | 6,558 | $2.00 | $13.1K | 2,510,041 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 4,687 | $2.18 | $10.2K | 187,100 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 63,058 | $2.18 | $137.5K | 2,516,599 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 25,220 | $2.18 | $55.0K | 1,006,591 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 7,611,458 | — | $0 | 8,661,225 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 288,114 | — | $0 | 288,114 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-23 | 550,000 | — | $0 | 550,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-23 | 550,000 | — | $0 | 550,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-12-23 | 2022-12-28 | 137,931 | $7.25 | $1000.0K | 4,882,854 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-11-07 | 2022-11-09 | 192,000 | $5.21 | $1.00M | 16,734,518 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-21 | 1,342,065 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-21 | 8,593,750 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-21 | 2,441,407 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion | 2022-09-19 | 2022-09-21 | 5,479,071 | — | $0 | 5,479,071 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | P Buy | 2022-09-19 | 2022-09-21 | 300,000 | $17.00 | $5.10M | 5,779,071 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-18 | 38,450 | — | $0 | 38,450 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-18 | 207,500 | — | $0 | 207,500 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-18 | 64,050 | — | $0 | 64,050 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-18 | 457,400 | $2.42 | $1.11M | 1,973,881 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-18 | 762,400 | $2.42 | $1.85M | 762,400 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-18 | 2,470,200 | $2.42 | $5.98M | 4,744,923 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,136,250 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 170,437 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 170,437 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 226,704 | $55.00 | $12.47M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 226,704 | $55.00 | $12.47M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 1,511,362 | $55.00 | $83.12M | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-06-24 | 2022-06-28 | 306,027 | $21.31 | $6.52M | 3,534,537 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-06-24 | 2022-06-28 | 35,944 | $21.31 | $766.0K | 415,142 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2022-05-04 | 2022-05-05 | 303,500 | $1.94 | $588.8K | 6,841,423 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2022-05-03 | 2022-05-05 | 221,500 | $1.93 | $427.5K | 6,537,923 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-08 | 2022-04-08 | 102,800 | $20.71 | $2.13M | 451,086 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-08 | 2022-04-08 | 97,200 | $20.71 | $2.01M | 3,840,564 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-07 | 2022-04-08 | 177,196 | $20.66 | $3.66M | 553,886 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-07 | 2022-04-08 | 167,800 | $20.66 | $3.47M | 3,937,764 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-06 | 2022-04-08 | 171,204 | $20.69 | $3.54M | 731,082 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-06 | 2022-04-08 | 162,000 | $20.69 | $3.35M | 4,105,564 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-15 | 2022-02-15 | 9,000 | $9.96 | $89.6K | 3,509,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-14 | 2022-02-15 | 10,000 | $9.89 | $98.9K | 3,500,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-14 | 2022-02-15 | 20,700 | $9.98 | $206.6K | 3,490,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-11 | 2022-02-15 | 156,000 | $10.22 | $1.59M | 3,469,330 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 56,244 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 374,962 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 56,244 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 56,244 | $13.20 | $742.4K | 226,704 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 374,962 | $13.20 | $4.95M | 1,511,362 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 56,244 | $13.20 | $742.4K | 226,704 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-21 | 2022-01-21 | 111,896 | $9.97 | $1.12M | 16,542,652 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2022-01-20 | 2022-05-05 | 50,800 | $5.00 | $254.0K | 6,316,423 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-20 | 2022-01-21 | 35,000 | $9.95 | $348.3K | 16,430,756 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2022-01-20 | 2022-01-24 | 369,100 | $5.42 | $2.00M | 6,634,723 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2022-01-19 | 2022-01-20 | 43,300 | $5.11 | $221.3K | 6,265,623 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-19 | 2022-01-21 | 11,521 | $9.97 | $114.9K | 16,395,756 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2022-01-18 | 2022-01-20 | 114,700 | $5.46 | $626.3K | 6,222,323 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2022-01-14 | 2022-01-20 | 10,300 | $5.60 | $57.7K | 6,107,623 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-13 | 2022-01-13 | 17,320 | $9.43 | $163.3K | 16,384,235 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2022-01-13 | 2022-01-13 | 41,800 | $5.52 | $230.7K | 6,097,323 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-12 | 2022-01-13 | 18,897 | $10.06 | $190.1K | 16,366,915 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2022-01-12 | 2022-01-13 | 100,000 | $5.65 | $565.0K | 6,055,523 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-11 | 2022-01-13 | 1,600 | $9.81 | $15.7K | 16,341,118 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-11 | 2022-01-13 | 6,900 | $10.67 | $73.6K | 16,348,018 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 8,200 | $5.53 | $45.3K | 5,955,523 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2021-12-16 | 2021-12-17 | 36,500 | $19.07 | $696.1K | 245,898 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2021-12-16 | 2021-12-17 | 356,800 | $19.07 | $6.80M | 2,403,566 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion deriv | 2021-10-12 | 2021-10-14 | 14,903,718 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion deriv | 2021-10-12 | 2021-10-14 | 436,650 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion deriv | 2021-10-12 | 2021-10-14 | 873,300 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2021-10-12 | 2021-10-14 | 62,500 | $16.00 | $1.00M | 499,150 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2021-10-12 | 2021-10-14 | 562,500 | $16.00 | $9.00M | 16,339,518 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion | 2021-10-12 | 2021-10-14 | 436,650 | — | $0 | 436,650 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion | 2021-10-12 | 2021-10-14 | 15,777,018 | — | $0 | 15,777,018 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-07 | 2021-09-08 | 26 | $33.93 | $882 | 96,190 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-07 | 2021-09-08 | 861 | $33.93 | $29.2K | 3,177,041 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-03 | 2021-09-08 | 6,985 | $34.00 | $237.5K | 3,177,902 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-03 | 2021-09-08 | 212 | $34.00 | $7.2K | 96,216 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-02 | 2021-09-02 | 483 | $34.24 | $16.5K | 96,428 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-02 | 2021-09-02 | 15,941 | $34.24 | $545.8K | 3,184,887 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-01 | 2021-09-02 | 382 | $33.98 | $13.0K | 96,911 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-01 | 2021-09-02 | 12,586 | $33.98 | $427.7K | 3,200,828 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-31 | 2021-09-02 | 249 | $33.94 | $8.5K | 97,293 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-31 | 2021-09-02 | 8,223 | $33.94 | $279.1K | 3,213,414 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-30 | 2021-08-30 | 197 | $33.92 | $6.7K | 97,542 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-30 | 2021-08-30 | 6,500 | $33.92 | $220.5K | 3,221,637 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-27 | 2021-08-30 | 209 | $33.94 | $7.1K | 97,739 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-27 | 2021-08-30 | 6,884 | $33.94 | $233.6K | 3,228,137 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-26 | 2021-08-30 | 126 | $34.52 | $4.3K | 97,948 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-26 | 2021-08-30 | 4,157 | $34.52 | $143.5K | 3,235,021 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-25 | 2021-08-25 | 208 | $34.34 | $7.1K | 98,074 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-25 | 2021-08-25 | 6,874 | $34.34 | $236.1K | 3,239,178 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-24 | 2021-08-25 | 119 | $34.07 | $4.1K | 98,282 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-24 | 2021-08-25 | 3,920 | $34.07 | $133.6K | 3,246,052 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-23 | 2021-08-25 | 209 | $34.06 | $7.1K | 98,401 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-23 | 2021-08-25 | 6,885 | $34.06 | $234.5K | 3,249,972 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-18 | 2021-08-19 | 2,852 | $33.99 | $96.9K | 3,256,857 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-18 | 2021-08-19 | 78 | $33.99 | $2.7K | 98,610 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-17 | 2021-08-19 | 512 | $34.12 | $17.5K | 98,688 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-17 | 2021-08-19 | 16,886 | $34.12 | $576.2K | 3,259,439 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2021-07-16 | 2021-07-16 | 1,666,666 | $6.00 | $10.00M | 1,666,666 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2021-07-16 | 2021-07-23 | 1,666,666 | $6.00 | $10.00M | 4,199,068 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 918,295 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 714,285 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,071,428 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 612,196 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 1,989,723 | — | $0 | 1,989,723 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 1,326,481 | — | $0 | 1,326,481 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 190,000 | $17.00 | $3.23M | 1,516,481 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 285,000 | $17.00 | $4.84M | 2,274,723 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 118,398 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 24,555 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 9,461 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 50,501 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 2,651,042 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 243,494 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 9,461 | — | $0 | 59,962 | SEC↗ |